Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach
Christopher B. Fox(Utah State University), Steven G. Reed(Infectious Disease Research Institute), Timothy Fouts(Profectus Biosciences (United States)), Traci J.T. Mikasa(Infectious Disease Research Institute), Elyse A. Beebe(Infectious Disease Research Institute), Sarah C Parker(Infectious Disease Research Institute), Ghislain Ismael Nana(Infectious Disease Research Institute), Mark A. Tomai(3M (United States)), Mark T. Orr(Center for Global Development), Tony Phan(Infectious Disease Research Institute), Sharvari Waghmare Joshi(Infectious Disease Research Institute), James Elvecrog(3M (United States)), Neal Van Hoeven(Sana Biotechnology (United States))
Cited by 65
Related Papers
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k
Key roles of adjuvants in modern vaccines
|Nature Medicine|2013|1.4k
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air
|Proceedings of the National Academy of Sciences|2009|224
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility
|Proceedings of the National Academy of Sciences|2008|198